January 25, 2019
Clinical study results will be presented in World Parkinson Conference 2019. Click here for further details of the conference.
October 15, 2017
The US patent was granted in October 2017. As of now, the FDA application can be pursued for the US market.
June 25, 2017
The results of the Short-term Effect Clinical Trials were published in June 2017 as an article in the Frontiers’ in Human Neuroscience journal. This journal is a highly regarded publication in this field; the details of which can be accessed via the Publication section on the Research tab.
June 15, 2017
The European Patent was granted on June, 2017. Therefore, the process of entering the market in both Turkey and European countries will be gaining speed.
June 01, 2016
Preliminary results of our clinical study is presented in Neuromodulation: The Science 2016 Conference held in San Francisco.